Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerAdipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivityAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionNovel repressor regulates insulin sensitivity through interaction with Foxo1PPARdelta regulates glucose metabolism and insulin sensitivityDeletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistanceThe role of circadian clocks in metabolic diseaseNuclear receptor corepressors and PPARgammaIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesityOrphan nuclear receptors and the regulation of nutrient metabolism: understanding obesityRoad to exercise mimetics: targeting nuclear receptors in skeletal muscleAdipogenesisHypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significanceAndrogen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cellsPPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesNrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitisHzf regulates adipogenesis through translational control of C/EBPalphaPPARγ in vagal neurons regulates high-fat diet induced thermogenesisHistone methylation regulator PTIP is required for PPARgamma and C/EBPalpha expression and adipogenesisPPARγ activation attenuates cold-induced upregulation of thyroid status and brown adipose tissue PGC-1α and D2Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complexFat storage-inducing transmembrane protein 2 is required for normal fat storage in adipose tissueThe m subunit of murine translation initiation factor eIF3 maintains the integrity of the eIF3 complex and is required for embryonic development, homeostasis, and organ size controlTwist-1 is a PPARdelta-inducible, negative-feedback regulator of PGC-1alpha in brown fat metabolismFat/vessel-derived secretory protein (Favine)/CCDC3 is involved in lipid accumulationCre Recombinase Strains Used for the Study of Adipose Tissues and Adipocyte Progenitors.Cell autonomous lipin 1 function is essential for development and maintenance of white and brown adipose tissueNuclear receptors as drug targets for metabolic disease.Increased renin production in mice with deletion of peroxisome proliferator-activated receptor-gamma in juxtaglomerular cells.Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice.Esrrb-Cre excises loxP-flanked alleles in early four-cell embryos.Ppargamma2 is a key driver of longevity in the mouse.Meta-analysis discovery of tissue-specific DNA sequence motifs from mammalian gene expression dataSystemic PPARγ deletion impairs circadian rhythms of behavior and metabolism.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue.Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.
P2860
Q21328702-C2EFB74C-339C-4B13-A4FA-1738C9FDFC0EQ24296924-EC5EF8FE-A4C3-44D0-AE9F-0C8BD34FBB7AQ24300694-4731BBD7-FDA5-4F76-BCD6-516D4FF5A800Q24314731-B95459FC-7123-49C0-8835-2D2C6CC4B26EQ24541495-A40DA8A8-4A62-4243-B09E-CD9733E8FBDBQ24555727-A368AB84-A2E9-48D4-BB76-8CB972EC1D08Q24597882-71BE9AB4-0414-45E4-9081-8D1A0CFDD92EQ25257827-DB5A6A0F-2F79-46B5-B1A6-58EAC12093CFQ26739984-479F9210-7E79-4159-ACC2-2E3198AAD07DQ26749072-9E7C8BD3-E651-4D51-99EA-79E28EAB4DD0Q26823819-F3F5B93A-9C24-48AC-B58A-DABF627ACA45Q26825855-B34371D5-D1D8-4418-BC1E-8FEFAF11BE63Q26828614-AE0C864E-E98F-4A29-9448-5C5BED165E34Q26865140-DA1363A7-5DC0-46CA-A242-AD7EAF5B74E2Q27013914-E505F2A0-337C-4251-B947-3473A379BAD6Q27024799-18D5852D-3667-4FB3-AE65-95863E8A294CQ28221639-BBA14CD0-9DDD-4C6C-A1E9-D919F729A278Q28392304-CBA9E75B-1776-4DB0-A2A6-E98B47692569Q28507261-805D7BFC-2863-4AFD-AC79-3B60500185BAQ28509162-39513C31-0DF0-4AC8-AB52-201329329723Q28513731-86CBA233-96C2-4081-A089-EB128F288B6BQ28575563-12A1726E-2CD6-444A-8A01-8347B71A7BCEQ28585312-C942553E-540D-4A0C-A394-56AE1FE74804Q28587329-D6FBCC08-79C4-4BED-9ACF-87ADEE539EACQ28589619-D4BE44F8-BE68-468F-8623-04D990E5BF70Q28589713-5A8DDA4A-430B-43A8-9549-3C33499EB253Q28593580-A0A5617E-A7A5-424E-8F38-E87FD9A245A6Q30241907-C23A89DA-E688-4B4D-99C1-76D624134588Q30419099-803869D2-8931-4C6D-B847-3AEE8AC64EFDQ30430126-E9A4DBBA-D0EF-4348-A495-8E4D9FB27F65Q30433046-9E095716-5277-4052-8A4D-1AB00D547C51Q30480233-85AD047F-37D8-4DCE-B2FB-570566A5198DQ30700197-26EB00DD-EF5E-436B-8227-1FB78B22966DQ30975227-D17CB71B-DC32-419B-B50A-470632589231Q31038373-7F24B55B-B227-4F1C-8C22-25BDE5A87CAEQ31085671-2EEEA113-CDB8-4867-8A08-8F5658001622Q33283063-7342BB70-7A7F-4EBA-A0F1-BF1482F4FC17Q33347137-291B7DEB-D94C-442D-8C55-CA3784F36696Q33510159-CAD9CCEA-5F4B-4EF3-AE13-A34576EB3884Q33559605-DAF85962-4D70-4FCA-A9A9-6355D1547848
P2860
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@ast
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@en
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@nl
type
label
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@ast
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@en
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@nl
prefLabel
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@ast
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@en
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@nl
P2093
P2860
P356
P1476
Adipose-specific peroxisome pr ...... t and liver but not in muscle.
@en
P2093
Andrea Hevener
Debbie Liao
Estelita Ong
Michael Nelson
Peter Olson
Yaacov Barak
P2860
P304
15712-15717
P356
10.1073/PNAS.2536828100
P407
P577
2003-12-05T00:00:00Z